What causes hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hyperkalemia

Hyperkalemia is primarily caused by decreased potassium excretion, increased potassium intake, or transcellular potassium shifts, with medication use and renal impairment being the most common clinical factors. 1, 2

Common Causes of Hyperkalemia

1. Decreased Potassium Excretion

  • Renal dysfunction:

    • Chronic kidney disease (CKD), especially when eGFR <60 mL/min/1.73m² 1
    • Acute kidney injury
    • Risk progressively increases as eGFR decreases 1
    • Present in up to 73% of patients with advanced CKD 1
  • Medications that decrease potassium excretion 1:

    • Renin-angiotensin-aldosterone system inhibitors (RAASi):
      • ACE inhibitors
      • Angiotensin receptor blockers (ARBs)
      • Direct renin inhibitors (aliskiren)
      • Mineralocorticoid receptor antagonists (MRAs)
    • Potassium-sparing diuretics (spironolactone, triamterene, amiloride)
    • NSAIDs
    • Beta-blockers
    • Calcineurin inhibitors (cyclosporine, tacrolimus)
    • Trimethoprim-sulfamethoxazole
    • Heparin
    • Pentamidine
    • Digitalis
    • Sacubitril/valsartan
    • Mannitol
    • Penicillin G

2. Increased Potassium Intake or Administration

  • Excessive dietary potassium intake 1:
    • Potassium supplements
    • Salt substitutes
    • High-potassium foods (bananas, melons, orange juice)
    • Herbal supplements (alfalfa, dandelion, hawthorne berry, nettle, noni juice)
  • Stored blood products transfusion 1
  • Intravenous potassium administration

3. Transcellular Shifts (Movement from Intracellular to Extracellular Space)

  • Metabolic acidosis
  • Insulin deficiency/hyperglycemia
  • Cell lysis (tumor lysis syndrome, rhabdomyolysis, hemolysis)
  • Medications affecting cellular potassium transport
  • Hyperkalemic periodic paralysis

4. Pseudo-hyperkalemia

  • Hemolysis during blood collection
  • Thrombocytosis
  • Leukocytosis
  • Prolonged tourniquet use
  • Fist clenching during blood draw 1

High-Risk Populations

Hyperkalemia risk is significantly higher in patients with:

  • Advanced CKD (present in up to 73% of patients) 1
  • Heart failure (present in up to 40% of patients) 1
  • Diabetes mellitus 1
  • Advanced age 1
  • Combination of these conditions 1
  • Male gender (slightly higher risk than females) 1

Clinical Significance

Hyperkalemia can be classified as:

  • Mild (5.0-5.5 mmol/L)
  • Moderate (5.6-6.5 mmol/L)
  • Severe (>6.5 mmol/L) 2

Even mild hyperkalemia (>5.0 mmol/L) is associated with increased mortality risk, particularly in patients with heart failure, CKD, or diabetes 2. Severe hyperkalemia can lead to cardiac arrhythmias, cardiac arrest, and death 1.

Prevention Strategies

For patients at risk of hyperkalemia:

  • Monitor serum potassium regularly, especially in high-risk patients
  • Review and adjust medications that can cause hyperkalemia
  • Consider dietary potassium restriction in advanced CKD
  • Implement lifestyle modifications including sodium restriction (<2g/day) and regular physical activity 2
  • Avoid potassium-containing IV fluids in at-risk patients 2
  • Consider potassium binders for chronic management in high-risk patients 2

Important Clinical Considerations

  • Hyperkalemia is often asymptomatic and discovered incidentally on routine blood tests 1
  • The worldwide incidence may be underestimated due to lack of routine potassium monitoring 1
  • Chronic or recurrent hyperkalemia is defined as potassium levels >5 mEq/L repetitively measured over a 1-year period 1
  • Always rule out pseudo-hyperkalemia when an unexpectedly high potassium level is found 1

Understanding these causes and risk factors is essential for early identification, prevention, and management of hyperkalemia in clinical practice.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperkalemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.